{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:07:26Z","timestamp":1772892446206,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20191"],"award-info":[{"award-number":["U20A20191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Development Fund of Beijing Rehabilitation Hospital, Capital Medical University","award":["2019-028"],"award-info":[{"award-number":["2019-028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10072-023-07273-y","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T02:01:54Z","timestamp":1703556114000},"page":"2011-2019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hyperglycemia affects axial signs in patients with Parkinson\u2019s disease through mechanisms of insulin resistance or non-insulin resistance"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-6691","authenticated-orcid":false,"given":"Ruidan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoxia","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-433X","authenticated-orcid":false,"given":"Boyan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"7273_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11910-018-0828-4","volume":"18","author":"B Deb\u00fb","year":"2018","unstructured":"Deb\u00fb B, De Oliveira GC, Lino JC, Moro E (2018) Managing gait, balance, and posture in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 18:23. https:\/\/doi.org\/10.1007\/s11910-018-0828-4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"7273_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10072-021-05700-6","volume":"43","author":"C Kobylecki","year":"2022","unstructured":"Kobylecki C, Shiderova I, Boca M, Michou E (2022) Falls risk is predictive of dysphagia in Parkinson\u2019s disease. Neurol Sci 43:1415\u20131417. https:\/\/doi.org\/10.1007\/s10072-021-05700-6","journal-title":"Neurol Sci"},{"key":"7273_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1590\/s1980-5764-2016dn1004005","volume":"10","author":"AF Barbosa","year":"2016","unstructured":"Barbosa AF, Chen J, Freitag F, Valente D, Souza CO, Voos MC et al (2016) Gait, posture and cognition in Parkinson\u2019s disease. Dement Neuropsychol 10:280\u2013286. https:\/\/doi.org\/10.1590\/s1980-5764-2016dn1004005","journal-title":"Dement Neuropsychol"},{"key":"7273_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/mds.21853","volume":"23","author":"C Marras","year":"2008","unstructured":"Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE (2008) Predictors of deterioration in health-related quality of life in Parkinson\u2019s disease: results from the DATATOP trial. Mov Disord 23:653\u2013659. https:\/\/doi.org\/10.1002\/mds.21853. (quiz 776)","journal-title":"Mov Disord"},{"key":"7273_CR5","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1212\/wnl.0000000000005475","volume":"90","author":"G Pagano","year":"2018","unstructured":"Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F et al (2018) Diabetes mellitus and Parkinson disease. Neurology 90:e1654\u2013e1662. https:\/\/doi.org\/10.1212\/wnl.0000000000005475","journal-title":"Neurology"},{"key":"7273_CR6","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2337\/dc08-0479","volume":"31","author":"C Becker","year":"2008","unstructured":"Becker C, Brobert GP, Johansson S, Jick SS, Meier CR (2008) Diabetes in patients with idiopathic Parkinson\u2019s disease. Diabetes Care 31:1808\u20131812. https:\/\/doi.org\/10.2337\/dc08-0479","journal-title":"Diabetes Care"},{"key":"7273_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1212\/wnl.60.1.87","volume":"60","author":"JC Pressley","year":"2003","unstructured":"Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S et al (2003) The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60:87\u201393. https:\/\/doi.org\/10.1212\/wnl.60.1.87","journal-title":"Neurology"},{"key":"7273_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/mds.27922","volume":"35","author":"SM Jeong","year":"2020","unstructured":"Jeong SM, Han K, Kim D, Rhee SY, Jang W, Shin DW (2020) Body mass index, diabetes, and the risk of Parkinson\u2019s disease. Mov Disord 35:236\u2013244. https:\/\/doi.org\/10.1002\/mds.27922","journal-title":"Mov Disord"},{"key":"7273_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","volume":"37","author":"D Athauda","year":"2022","unstructured":"Athauda D, Evans J, Wernick A, Virdi G, Choi ML, Lawton M et al (2022) The impact of type 2 diabetes in Parkinson\u2019s disease. Mov Disord 37:1612\u20131623. https:\/\/doi.org\/10.1002\/mds.29122","journal-title":"Mov Disord"},{"key":"7273_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/acn3.51343","volume":"8","author":"R Ou","year":"2021","unstructured":"Ou R, Wei Q, Hou Y, Zhang L, Liu K, Lin J et al (2021) Effect of diabetes control status on the progression of Parkinson\u2019s disease: a prospective study. Ann Clin Transl Neurol 8:887\u2013897. https:\/\/doi.org\/10.1002\/acn3.51343","journal-title":"Ann Clin Transl Neurol"},{"key":"7273_CR11","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.332122","volume":"17","author":"CM Labandeira","year":"2022","unstructured":"Labandeira CM, Fraga-Bau A, Arias Ron D, Alvarez-Rodriguez E, Vicente-Alba P, Lago-Garma J et al (2022) Parkinson\u2019s disease and diabetes mellitus: common mechanisms and treatment repurposing. Neural Regen Res 17:1652\u20131658. https:\/\/doi.org\/10.4103\/1673-5374.332122","journal-title":"Neural Regen Res"},{"key":"7273_CR12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/s0140-6736(17)31585-4","volume":"390","author":"D Athauda","year":"2017","unstructured":"Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K et al (2017) Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390:1664\u20131675. https:\/\/doi.org\/10.1016\/s0140-6736(17)31585-4","journal-title":"Lancet"},{"key":"7273_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.02.005","volume":"118","author":"F Bassil","year":"2014","unstructured":"Bassil F, Fernagut PO, Bezard E, Meissner WG (2014) Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? Prog Neurobiol 118:1\u201318. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.02.005","journal-title":"Prog Neurobiol"},{"key":"7273_CR14","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2022-0093","author":"LY Li","year":"2022","unstructured":"Li LY, Liu SF, Zhuang JL, Li MM, Huang ZP, Chen YH et al (2022) Recent research progress on metabolic syndrome and risk of Parkinson\u2019s disease. Rev Neurosci. https:\/\/doi.org\/10.1515\/revneuro-2022-0093","journal-title":"Rev Neurosci"},{"key":"7273_CR15","doi-asserted-by":"publisher","first-page":"4951379","DOI":"10.1155\/2019\/4951379","volume":"2019","author":"F Camargo Maluf","year":"2019","unstructured":"Camargo Maluf F, Feder D, de Siqueira A, Carvalho A (2019) Analysis of the relationship between type II diabetes mellitus and Parkinson\u2019s disease: a systematic review. Parkinsons Dis 2019:4951379. https:\/\/doi.org\/10.1155\/2019\/4951379","journal-title":"Parkinsons Dis"},{"key":"7273_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2013.01.016","volume":"19","author":"V Kotagal","year":"2013","unstructured":"Kotagal V, Albin RL, M\u00fcller ML, Koeppe RA, Frey KA, Bohnen NI (2013) Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 19:522\u2013526. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.016","journal-title":"Parkinsonism Relat Disord"},{"key":"7273_CR17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182553cc9","volume":"78","author":"E Cereda","year":"2012","unstructured":"Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G (2012) Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology 78:1507\u20131511. https:\/\/doi.org\/10.1212\/WNL.0b013e3182553cc9","journal-title":"Neurology"},{"key":"7273_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/1673-5374.320965","volume":"17","author":"A De Iuliis","year":"2022","unstructured":"De Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C (2022) Diabetes mellitus and Parkinson\u2019s disease: dangerous liaisons between insulin and dopamine. Neural Regen Res 17:523\u2013533. https:\/\/doi.org\/10.4103\/1673-5374.320965","journal-title":"Neural Regen Res"},{"key":"7273_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5582\/ddt.2015.01207","volume":"9","author":"Q Tang","year":"2015","unstructured":"Tang Q, Li X, Song P, Xu L (2015) Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discov Ther 9:380\u2013385. https:\/\/doi.org\/10.5582\/ddt.2015.01207","journal-title":"Drug Discov Ther"},{"key":"7273_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/mds.28545","volume":"36","author":"I Markaki","year":"2021","unstructured":"Markaki I, Ntetsika T, Sorjonen K, Svenningsson P (2021) Euglycemia indicates favorable motor outcome in Parkinson\u2019s disease. Mov Disord 36:1430\u20131434. https:\/\/doi.org\/10.1002\/mds.28545","journal-title":"Mov Disord"},{"key":"7273_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"7273_CR22","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"7273_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"7273_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2019.05.009","volume":"65","author":"GD Kuhlman","year":"2019","unstructured":"Kuhlman GD, Flanigan JL, Sperling SA, Barrett MJ (2019) Predictors of health-related quality of life in Parkinson\u2019s disease. Parkinsonism Relat Disord 65:86\u201390. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.05.009","journal-title":"Parkinsonism Relat Disord"},{"key":"7273_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/000348940811701210","volume":"117","author":"PC Belafsky","year":"2008","unstructured":"Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J et al (2008) Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 117:919\u2013924. https:\/\/doi.org\/10.1177\/000348940811701210","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"7273_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","volume":"114","author":"CA Rosen","year":"2004","unstructured":"Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2004) Development and validation of the voice handicap index-10. Laryngoscope 114:1549\u20131556. https:\/\/doi.org\/10.1097\/00005537-200409000-00009","journal-title":"Laryngoscope"},{"key":"7273_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1519\/jpt.0000000000000068","volume":"39","author":"JT Lang","year":"2016","unstructured":"Lang JT, Kassan TO, Devaney LL, Colon-Semenza C, Joseph MF (2016) Test-retest reliability and minimal detectable change for the 10-meter walk test in older adults with Parkinson\u2019s disease. J Geriatr Phys Ther 39:165\u2013170. https:\/\/doi.org\/10.1519\/jpt.0000000000000068","journal-title":"J Geriatr Phys Ther"},{"key":"7273_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S (1991) The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142\u2013148. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01616.x","journal-title":"J Am Geriatr Soc"},{"key":"7273_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS (2022) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 46:15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"key":"7273_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.29009","volume":"37","author":"M Uyar","year":"2022","unstructured":"Uyar M, Lezius S, Buhmann C, P\u00f6tter-Nerger M, Schulz R, Meier S et al (2022) Diabetes, glycated hemoglobin (HbA1c), and neuroaxonal damage in Parkinson\u2019s disease (MARK-PD Study). Mov Disord 37:1299\u20131304. https:\/\/doi.org\/10.1002\/mds.29009","journal-title":"Mov Disord"},{"key":"7273_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Bandres Ciga S et al (2021) Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression. Mov Disord 36:1420\u20131429. https:\/\/doi.org\/10.1002\/mds.28551","journal-title":"Mov Disord"},{"key":"7273_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.parkreldis.2014.02.016","volume":"20","author":"M Giuntini","year":"2014","unstructured":"Giuntini M, Baldacci F, Del Prete E, Bonuccelli U, Ceravolo R (2014) Diabetes is associated with postural and cognitive domains in Parkinson\u2019s disease. Results from a single-center study. Parkinsonism Relat Disord 20:671\u2013672. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.016","journal-title":"Parkinsonism Relat Disord"},{"key":"7273_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fnhum.2015.00246","volume":"9","author":"DJ Clark","year":"2015","unstructured":"Clark DJ (2015) Automaticity of walking: functional significance, mechanisms, measurement and rehabilitation strategies. Front Hum Neurosci 9:246. https:\/\/doi.org\/10.3389\/fnhum.2015.00246","journal-title":"Front Hum Neurosci"},{"key":"7273_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2015.06.014","volume":"82","author":"T Wu","year":"2015","unstructured":"Wu T, Hallett M, Chan P (2015) Motor automaticity in Parkinson\u2019s disease. Neurobiol Dis 82:226\u2013234. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.014","journal-title":"Neurobiol Dis"},{"key":"7273_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.16062","volume":"10","author":"K Takakusaki","year":"2017","unstructured":"Takakusaki K (2017) Functional neuroanatomy for posture and gait control. J Mov Disord 10:1\u201317. https:\/\/doi.org\/10.14802\/jmd.16062","journal-title":"J Mov Disord"},{"key":"7273_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-s","volume":"36","author":"JW Unger","year":"1991","unstructured":"Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36:343\u2013362. https:\/\/doi.org\/10.1016\/0301-0082(91)90015-s","journal-title":"Prog Neurobiol"},{"key":"7273_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9258(17)42297-6","volume":"269","author":"MF White","year":"1994","unstructured":"White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem 269:1\u20134","journal-title":"J Biol Chem"},{"key":"7273_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2016.01.020","volume":"318","author":"Y Pang","year":"2016","unstructured":"Pang Y, Lin S, Wright C, Shen J, Carter K, Bhatt A et al (2016) Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience 318:157\u2013165. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.020","journal-title":"Neuroscience"},{"key":"7273_CR39","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1038\/ncomms9543","volume":"6","author":"MA Stouffer","year":"2015","unstructured":"Stouffer MA, Woods CA, Patel JC, Lee CR, Witkovsky P, Bao L et al (2015) Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun 6:8543. https:\/\/doi.org\/10.1038\/ncomms9543","journal-title":"Nat Commun"},{"key":"7273_CR40","doi-asserted-by":"publisher","first-page":"R1082","DOI":"10.1152\/ajpregu.00449.2010","volume":"299","author":"JK Morris","year":"2010","unstructured":"Morris JK, Bomhoff GL, Stanford JA, Geiger PC (2010) Neurodegeneration in an animal model of Parkinson\u2019s disease is exacerbated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 299:R1082-1090. https:\/\/doi.org\/10.1152\/ajpregu.00449.2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7273_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2018.05.025","volume":"351","author":"S Sharma","year":"2018","unstructured":"Sharma S, Taliyan R (2018) High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats. Behav Brain Res 351:17\u201323. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.025","journal-title":"Behav Brain Res"},{"key":"7273_CR42","doi-asserted-by":"publisher","first-page":"9305025","DOI":"10.1155\/2016\/9305025","volume":"2016","author":"A Mustapa","year":"2016","unstructured":"Mustapa A, Justine M, Mohd Mustafah N, Jamil N, Manaf H (2016) Postural control and gait performance in the diabetic peripheral neuropathy: a systematic review. Biomed Res Int 2016:9305025. https:\/\/doi.org\/10.1155\/2016\/9305025","journal-title":"Biomed Res Int"},{"key":"7273_CR43","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/brain\/awt247","volume":"136","author":"ML M\u00fcller","year":"2013","unstructured":"M\u00fcller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA et al (2013) Thalamic cholinergic innervation and postural sensory integration function in Parkinson\u2019s disease. Brain 136:3282\u20133289. https:\/\/doi.org\/10.1093\/brain\/awt247","journal-title":"Brain"},{"key":"7273_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbr.2014.08.033","volume":"274","author":"KM Capiotti","year":"2014","unstructured":"Capiotti KM, De Moraes DA, Menezes FP, Kist LW, Bogo MR, Da Silva RS (2014) Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio). Behav Brain Res 274:319\u2013325. https:\/\/doi.org\/10.1016\/j.bbr.2014.08.033","journal-title":"Behav Brain Res"},{"key":"7273_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuroscience.2011.11.058","volume":"202","author":"A Sherin","year":"2012","unstructured":"Sherin A, Anu J, Peeyush KT, Smijin S, Anitha M, Roshni BT et al (2012) Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience 202:69\u201376. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.11.058","journal-title":"Neuroscience"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07273-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:41:32Z","timestamp":1713242492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07273-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["7273"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07273-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Beijing Rehabilitation Hospital of Capital Medical University ethics review board approved this study (approval No.2021bkky-001). All study participants gave written informed consents forms in accordance with the Declaration of Helsinki before study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}